Tilray Brands (TLRY) Receivables (2017 - 2026)
Tilray Brands (TLRY) reported Receivables of $118.4 million for Q1 2026, up 8.53% quarter-over-quarter from $109.1 million in Q4 2025.
Tilray Brands (TLRY) Receivables (2017 - 2026) Analysis & Trends
Tilray Brands has reported Receivables for 10 years, with the latest figure at $118.4 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $118.4 million; the trailing twelve-month figure through Feb 2026 stood at $118.4 million (changed N/A YoY), and the FY2025 full-year result was $121.5 million, up 19.46% from the prior year.
- Receivables for Q1 2026 stood at $118.4 million, up from $109.1 million in the prior quarter.
- The five-year high for Receivables was $121.5 million in Q2 2025, with the low at $78.3 million in Q1 2023.
- Historically, Receivables has averaged $98.4 million across 5 years, with a median of $96.8 million in 2022.
- Annual changes were most pronounced in 2023 — Receivables retreated 16.54% — and 2024, when it climbed 26.76%.
- Tilray Brands' Receivables stood at $89.7 million in 2022, then grew by 0.99% to $90.6 million in 2023, then grew by 24.44% to $112.7 million in 2024, then retreated by 3.25% to $109.1 million in 2025, then advanced by 8.53% to $118.4 million in 2026.
- The last three Receivables figures came in at $118.4 million (Q1 2026), $109.1 million (Q4 2025), and $107.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 355.67 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 149.62 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 118.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 118.37 Mn |
| Nov 30, 2025 | 109.07 Mn |
| Aug 31, 2025 | 107.08 Mn |
| May 31, 2025 | 121.49 Mn |
| Nov 30, 2024 | 112.74 Mn |
| Aug 31, 2024 | 104.04 Mn |
| May 31, 2024 | 101.70 Mn |
| Feb 29, 2024 | 89.54 Mn |
| Nov 30, 2023 | 90.60 Mn |
| Aug 31, 2023 | 82.08 Mn |
| May 31, 2023 | 86.23 Mn |
| Feb 28, 2023 | 78.34 Mn |
| Nov 30, 2022 | 89.71 Mn |
| Aug 31, 2022 | 98.35 Mn |
| May 31, 2022 | 95.28 Mn |
| Feb 28, 2022 | 89.90 Mn |
| Nov 30, 2021 | 84.58 Mn |
| Aug 31, 2021 | 97.18 Mn |
| May 31, 2021 | 87.31 Mn |
| May 31, 2020 | 37.93 Mn |